EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 356 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,000 | -40.0% | 95 | -17.4% | 0.00% | 0.0% |
| Q1 2022 | $5,000 | -85.3% | 115 | -85.1% | 0.00% | -83.3% |
| Q4 2021 | $34,000 | -64.2% | 773 | -59.3% | 0.01% | -64.7% |
| Q3 2021 | $95,000 | -20.2% | 1,900 | +0.8% | 0.02% | -22.7% |
| Q2 2021 | $119,000 | +11.2% | 1,885 | +63.8% | 0.02% | -12.0% |
| Q1 2021 | $107,000 | -1.8% | 1,151 | -5.4% | 0.02% | -7.4% |
| Q4 2020 | $109,000 | +541.2% | 1,217 | +628.7% | 0.03% | +350.0% |
| Q3 2020 | $17,000 | +30.8% | 167 | 0.0% | 0.01% | +20.0% |
| Q2 2020 | $13,000 | +44.4% | 167 | +1.8% | 0.01% | +25.0% |
| Q1 2020 | $9,000 | – | 164 | +3180.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 5 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | – | 5 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
| Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
| AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
| RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
| EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
| SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
| Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
| DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |